DoubleVerify agrees to acquire Scibids
Scibids builds AI that automates and optimises an advertiser’s programmatic buying of digital ad campaigns.
Stay updated with breaking news from Scibids Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scibids builds AI that automates and optimises an advertiser’s programmatic buying of digital ad campaigns.
Looking to extend what it claims is its leadership in the optimisation sector with “best-in-class” AI technology to maximise campaigns, digital media measuremen...
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
DoubleVerify Holdings, Inc (NYSE: DV) stock is trading lower Tuesday after it reported quarterly earnings of $0.07 per share, which beat the consensus of $0.06. The company reported quarterly sales of $133.74 million, which beat the consensus of $133.33 million.
The deal for Scibids will expand DV’s AI-powered campaign optimization solutions